항균 치료제 시장 : 약제 클래스별, 투여 경로별, 적응 질환별, 유통 채널별 및 지역별

The global antimicrobial therapeutics market size was valued at US$ 110.20 Bn in 2023 and is expected to reach US$ 161.77 Bn by 2030, grow at a compound annual growth rate (CAGR) of 5.6% from 2023 to 2030.

Figure 1. Global Antimicrobial Therapeutics Market Share (%), by Region, 2023

Antimicrobial therapeutics are medicines that kill or make it harder for bacteria to grow and multiply in people or animals. They are often used to treat serious infections, such as pneumonia or bloodstream infections (BSIs). Antibiotics can be taken by mouth in the form of pills, tablets, or liquids. They can also be injected or given directly into the bloodstream (IV) for more severe infections. They can also be applied to the skin as a cream, spray, or ointment. When used incorrectly, antibiotics can cause serious side effects and lead to resistant microorganisms. This resistance makes it harder to treat infections with the same medicine or even other medicines that are effective against them. Antimicrobial therapeutics are medications used to treat infections caused by microorganisms, including bacteria, viruses, fungi, and parasites. These therapeutics work by either killing the microorganisms or inhibiting their growth. However, the misuse and overuse of these drugs have led to the emergence of antimicrobial resistance, which is a significant global health concern. The global antimicrobial therapeutics market is expected to grow due to the increasing prevalence of infectious diseases, the development of new drugs, and the growing awareness of antimicrobial resistance.

Market Dynamics:

Increasing product approval by regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, Zydus Lifesciences, a pharmaceutical company, announced that it had received final approval from the U.S. Food and Drug Administration (FDA) to market its antifungal medicine Micafungin, which is used to treat certain types of fungal or yeast infections.

Key features of the study:

• This report provides in-depth analysis of the global antimicrobial therapeutics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global antimicrobial therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Sanofi SA, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., AbbVie Inc., Allergan plc, Mylan N.V. and Alembic Pharmaceuticals Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global antimicrobial therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial therapeutics market

Detailed Segmentation:

• Global Antimicrobial Therapeutics Market, By Drug Class:
  • Antibacterials
  • Antivirals
  • Antifungals
  • Antiparasitics
• Global Antimicrobial Therapeutics Market, By Route of Administration:
  • Oral
  • Topical
  • Injectable
  • Others
• Global Antimicrobial Therapeutics Market, By Disease Indication:
  • Respiratory Infections
  • Urinary Tract Infections (UTIs)
  • Skin and Soft Tissue Infections
  • Sexually Transmitted Infections (STIs)
  • Gastrointestinal Infections
  • Central Nervous System Infections
  • Others
• Global Antimicrobial Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Antimicrobial Therapeutics Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • AstraZeneca plc
  • Sanofi SA
  • Bayer AG
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Allergan plc
  • Mylan N.V.
  • Alembic Pharmaceuticals Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Antimicrobial Therapeutics, By Drug Class
  • Market Antimicrobial Therapeutics, By Route of Administration
  • Market Antimicrobial Therapeutics, By Disease Indication
  • Market Antimicrobial Therapeutics, By Distribution Channel
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Antimicrobial Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Antimicrobial Therapeutics Market , By Drug Class, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Antibacterials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Antivirals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Antifungals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Antiparasitics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Antimicrobial Therapeutics Market , By Route of Administration, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Antimicrobial Therapeutics Market , By Disease Indication, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Respiratory Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Urinary Tract Infections (UTIs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Skin and Soft Tissue Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Sexually Transmitted Infections (STIs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Gastrointestinal Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Central Nervous System Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Antimicrobial Therapeutics Market , By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Antimicrobial Therapeutics Market , By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,2018 - 2030, (US$ Bn )
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn )
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn )
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
• GlaxoSmithKline plc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche AG
• AstraZeneca plc.
• Sanofi SA
• Bayer AG
• Bristol Myers Squibb Company
• Eli Lilly and Company
• Gilead Sciences, Inc.
• AbbVie Inc.
• Allergan plc
• Mylan N.V.
• Alembic Pharmaceuticals Limited
• Analyst Views

11. Section

• Research Methodology
• About us